Literature DB >> 9114905

The effects of age on the pharmacokinetics and pharmacodynamics of single oral doses of benazepril and enalapril.

N J Macdonald1, A Sioufi, C A Howie, J R Wade, H L Elliott.   

Abstract

1. Eighteen healthy, normotensive subjects (nine young and nine elderly) participated in a double-blind, 3-way, crossover study to compare aspects of the pharmacokinetics and pharmacodynamics of single oral doses of 10 mg benazepril, 10 mg enalapril and placebo. 2. The hypotensive effect was similar after both drugs but the absolute reductions were greater in the elderly who had higher initial levels of blood pressure. 3. The AUCs for both benazeprilat and enalaprilat were higher in the elderly but by a significantly greater amount for enalaprilat (+ 113% vs 40%; P < 0.01). 4. The AUCs for both drugs tended to be highest in subjects with the lowest creatinine clearance. 5. The changes in kinetics and dynamics observed in the elderly after benazepril are qualitatively similar to those with other ACE inhibitors. The clinical significance of the quantitative differences requires further investigation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 9114905      PMCID: PMC1364639          DOI: 10.1111/j.1365-2125.1993.tb04218.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  14 in total

1.  Effect on aging on plasma renin and aldosterone in normal man.

Authors:  P Weidmann; S De Myttenaere-Bursztein; M H Maxwell; J de Lima
Journal:  Kidney Int       Date:  1975-11       Impact factor: 10.612

2.  A liquid chromatography-assisted assay for angiotensin-converting enzyme (peptidyl dipeptidase) in serum.

Authors:  S G Chiknas
Journal:  Clin Chem       Date:  1979-07       Impact factor: 8.327

3.  Initial dose of enalapril in hypertension.

Authors:  J Webster; D M Newnham; J C Petrie
Journal:  Br Med J (Clin Res Ed)       Date:  1985-06-01

4.  Age and the pharmacokinetics and pharmacodynamics of chronic enalapril treatment.

Authors:  K R Lees; J L Reid
Journal:  Clin Pharmacol Ther       Date:  1987-06       Impact factor: 6.875

5.  Age and the pharmacokinetics of angiotensin converting enzyme inhibitors enalapril and enalaprilat.

Authors:  N Hockings; A A Ajayi; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1986-04       Impact factor: 4.335

6.  Pharmacokinetics and pharmacodynamics of the ace inhibitor benazepril hydrochloride in the elderly.

Authors:  G Kaiser; R Ackermann; W Dieterle; C J Durnin; J McEwen; K Ghose; A Richens; I B Holmes
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

7.  Effects of an angiotensin-converting enzyme inhibitor (captopril) on blood pressure in anephric subjects.

Authors:  A J Man in 't Veld; I M Schicht; F H Derkx; J H de Bruyn; M A Schalekamp
Journal:  Br Med J       Date:  1980-02-02

8.  The hypotensive effect of captopril in hypertensive patients is age-related.

Authors:  P Lijnen; R Fagard; D Groeseneken; J R M'Buyamba; J Staessen; A Amery
Journal:  Methods Find Exp Clin Pharmacol       Date:  1983-11

9.  Post-marketing surveillance of enalapril: experience in 11,710 hypertensive patients in general practice.

Authors:  W D Cooper; D Sheldon; D Brown; G R Kimber; V L Isitt; W J Currie
Journal:  J R Coll Gen Pract       Date:  1987-08

10.  Factors related to first dose hypotensive effect of captopril: prediction and treatment.

Authors:  G P Hodsman; C G Isles; G D Murray; T P Usherwood; D J Webb; J I Robertson
Journal:  Br Med J (Clin Res Ed)       Date:  1983-03-12
View more
  6 in total

Review 1.  Age-related changes in protein binding of drugs: implications for therapy.

Authors:  M K Grandison; F D Boudinot
Journal:  Clin Pharmacokinet       Date:  2000-03       Impact factor: 6.447

Review 2.  Cardiovascular drug therapy in elderly patients: specific age-related pharmacokinetic, pharmacodynamic and therapeutic considerations.

Authors:  Arduino A Mangoni
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

Review 3.  Pharmacokinetic and pharmacodynamic changes in the elderly. Clinical implications.

Authors:  A Hämmerlein; H Derendorf; D T Lowenthal
Journal:  Clin Pharmacokinet       Date:  1998-07       Impact factor: 6.447

4.  A comparison in young and elderly subjects of the pharmacokinetics and pharmacodynamics of single and multiple doses of benazepril.

Authors:  N J Macdonald; H L Elliott; D M Hughes; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1993-09       Impact factor: 4.335

Review 5.  Optimal dosage of ACE inhibitors in older patients.

Authors:  B Tomlinson
Journal:  Drugs Aging       Date:  1996-10       Impact factor: 3.923

Review 6.  Clinical pharmacokinetics of vasodilators. Part I.

Authors:  R Kirsten; K Nelson; D Kirsten; B Heintz
Journal:  Clin Pharmacokinet       Date:  1998-06       Impact factor: 6.447

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.